Navigation Links
Diversionary Therapy Announces First Sale of ditto™ dental
Date:5/22/2012

NEW YORK, May 22, 2012 /PRNewswire/ -- Diversionary Therapy Technologies (DTT) is pleased to announce the first sale of its innovative new product, ditto™ dental, to Manhattan Pediatric Dental Group PC.   "We're excited to add ditto dental to our state-of-the-art pediatric dental care.  We trialed it in our office and had spectacular results," states Dr. Mark Hochberg, principal, of Manhattan Pediatric Dental Group.

ditto™ dental is a clinical tool developed from medical research which has been shown to reduce anxiety and stress for children aged 3-14 years. The procedural stories, covering all dental procedures, are chosen from the dentist menu to help prepare the children and their families for their treatment. By showing the videos before the procedure, treatment times have been shortened, anxiety reduced and better overall patient outcomes have resulted.  The portable device uses augmented reality, a multi-modal sensory-based distraction medium to engage children.  The user interface has other fun tangible interaction thanks to the touch screen and the motion sensors and can be used in a variety of positions.

Dr. Hochberg also added, "Taking your child to the dentist can be a very stressful experience for some children. It is important for us to be able to manage the child and reduce their apprehension during pediatric dental procedures.  We have purchased several devices because we found that showing the ditto™ dental pre-procedural videos helped relieve anxiety and lead to a better patient outcome."

The console also includes interactive games and immersive stories to engage the patient while waiting for procedures.  Pediatric dentists, orthodontists, child life specialists and animation experts have developed the ditto™ dental over the past couple of years and new content will continue to be added.

DTT will formally debut the ditto™ dental at the American Acad
'/>"/>

SOURCE Diversionary Therapy Technologies
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
2. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
3. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
4. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
5. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
6. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
7. Progenitor Cell Therapy Secures Industry Accreditation
8. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
9. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
10. First Coast Oncology to Offer Next Generation Proton Therapy
11. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Vermillion, Inc. (Nasdaq:   VRML), a ... today that investors including Oracle Investment Management, ... several Vermillion directors have agreed to purchase approximately ... stock and warrants to purchase unregistered shares of ... Under the terms of the private ...
(Date:12/24/2014)... and NEW YORK , ... from its open-label pilot study of mazindol in children ... Development and Therapy in December 2014 . ... mazindol in children with attention deficit/hyperactivity disorder" ( Konofal ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) shows ...
(Date:12/22/2014)... HILL, N.C. , Dec. 22, 2014 /PRNewswire/ ... today announced that it has signed a letter ... company that has developed and patented a nanotechnology-based ... medical diagnostics products that enable rapid on-site collection ... alcohol use/abuse and health issues in an immediate, ...
(Date:12/22/2014)... ITRA Global, one of the largest ... real estate, has further expanded its global reach with ... Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman of ... Global / ACORPP (Australian Corporate Property and Projects) , ... property services to a wide range of clients in ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... Systems, a leader in the field of,sleep diagnostic ... an,exclusive agreement with the Beth Israel Deaconess Medical ... Coupling (CPC) technology,developed by Drs. Robert Thomas, Ary ... technology represents a breakthrough in how sleep can ...
... LOS ALAMOS, New Mexico, December 13, 2007In collaboration ... Alamos, an international team of researchers has, for ... formation of mysterious metallic puddles that facilitate the ... electrically conducting one. , The research may lead ...
... 13 Neurocrine Biosciences,Inc. (Nasdaq: NBIX ) announced ... Diego campus, as a part of its restructuring program,to ... expenses after the setback on indiplon. Following these reductions,Neurocrine ... great disappointment that we have to make this difficult,decision ...
Cached Biology Technology:Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology 2Collaboration yields 'the right glasses' for observing mystery behavior in electrons 2Collaboration yields 'the right glasses' for observing mystery behavior in electrons 3Neurocrine Announces Work Force Restructuring 2Neurocrine Announces Work Force Restructuring 3
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:11/21/2014)... 2014 According to a new ... (Video, RFID, Access Control, Intrusion Detection, Parking Management, Under ... Component Service Geography - Global Forecasts to 2020", published ... to be around $25 Billion in 2014 and is ... a CAGR of 8.69%. Browse 116 market ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... only has the potential to become part of a single-dose ... able to block transmission of the parasite from person to ... Malaria Venture (MMV), based in Switzerland, and the Drug Discovery ... South Africa. On the basis of initial results it was ...
... certain genes in the E2F group, and to understand how ... behind it. This researcher works at the laboratory of Ana ... Country (UPV/EHU); this was where an article that appeared in ... 2010 on this line of research was published. The keys ...
... rely on Lake Taihu for drinking water but about 20 ... had become overrun with toxic blue-green algae which can damage ... the University of Tennessee, Knoxville, will be working on an ... totaling $2.5 million to resolve the ecosystem balance in the ...
Cached Biology News:African research identifies strong candidate for possible single-dose malaria cure 2African research identifies strong candidate for possible single-dose malaria cure 3A mechanism providing clues for research into pancreatic diabetes is described 2A mechanism providing clues for research into pancreatic diabetes is described 3University of Tennessee Team receives NSF support to study toxic water in China 2
Human Legumain Affinity Purified Polyclonal Ab...
Human Cystatin F MAb (Clone 292103)...
... is an inhibitor of ... concentration of inhibitor required ... must be determined empirically ... micromolar inhibitor is sufficient ...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
Biology Products: